NCT05451667View on ClinicalTrials.gov

Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Safety and Tolerability
Interventions
DRUG

YJ001 for Spray Use

YJ001 (active ingredient)

DRUG

Placebo of YJ001 for Spray Use

Hydroxypropyl Methylcellulose

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
collaborator

Zhejiang Yuejia Pharmaceuticals Co., Ltd.

INDUSTRY

lead

Yuejia Pharmaceuticals (USA), Inc.

INDUSTRY